Max Healthcare Institute (MAXHEALTH) — Board Meeting

Max Healthcare's board approved Q3 FY2025-26 results with revenue from operations at ₹2,06,752 lakhs (up 10.7% YoY) and net profit of ₹30,092 lakhs. Key corporate actions include the NCLT-approved merger of Crosslay Remedies with Jaypee Healthcare (effective December 15, 2025), a ₹1,02,000 lakhs investment for a 450-bed Pune hospital, and ₹7,899 lakhs tax reversal from the merger. The company also granted 28,03,080 stock options at ₹900/share and extended the Dwarka facility Services Agreement for 260 additional beds.

📄 View Original Announcement (PDF)

📊 Stock Analysis — MAXHEALTH ✨ Ask AI About This

About Max Healthcare Institute Limited (MAXHEALTH)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,02,200.33 Cr P/E: 101.2

View full MAXHEALTH stock details →

📡 Get AI alerts when MAXHEALTH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MAXHEALTH — Free

💡 Ask AI about this filing

"How does this board meeting affect Max Healthcare Institute Limited's outlook?" "What did Max Healthcare Institute Limited announce on 5 February 2026?" "Is this positive or negative for MAXHEALTH?"

Ask AI Free →

📊 More MAXHEALTH filings

See all MAXHEALTH filings →

🔥 Also filed on 5 February 2026

500312 Oil and Natural Gas Corporation Ltd Corporate Action 501144 Peoples Investments Ltd Financial Results TATAPOWER Tata Power Company Limited Financial Results SIEMENS Siemens Limited Announcement 500068 Disa India Ltd Financial Results 505750 Josts Engineering Company Ltd Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MAXHEALTH files new disclosures

Track MAXHEALTH filings, board meetings, and corporate actions. Free email alerts at 5 PM.